Knuff & Co LLC Buys Shares of 6,462 Danaher Corporation $DHR

Key Points

• Knuff & Co LLC initiated a position in Danaher by purchasing 6,462 shares valued at approximately $1.23 million. Institutional investors and hedge funds collectively own 79.05% of the company.
• Analysts maintain a generally positive outlook, with Danaher receiving a “Moderate Buy” consensus rating and an average price target of $228.91, despite several recent target-price reductions.
• Danaher’s latest quarterly results exceeded expectations, with adjusted EPS of $1.94 versus the $1.85 estimate and revenue of $6.26 billion, up 5.5% year over year.

Knuff & Co LLC bought a new position in shares of Danaher Corporation (NYSE:DHR - Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 6,462 shares of the conglomerate's stock, valued at approximately $1,231,000.

Several other institutional investors also recently modified their holdings of the stock. NewEdge Wealth LLC bought a new stake in shares of Danaher in the 2nd quarter valued at about $1,879,000. Generation Investment Management LLP bought a new position in Danaher during the 2nd quarter worth approximately $1,287,949,000. Flossbach Von Storch SE bought a new position in Danaher during the 2nd quarter worth approximately $747,260,000. Empirical Asset Management LLC acquired a new position in Danaher during the second quarter valued at approximately $241,000. Finally, Chancellor Financial Group WB LP bought a new stake in Danaher in the second quarter valued at approximately $545,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

DHR has been the topic of several analyst reports. Weiss Ratings upgraded shares of Danaher from a "sell (d+)" rating to a "hold (c-)" rating in a report on Wednesday, July 15th. Guggenheim lowered their price objective on shares of Danaher from $235.00 to $200.00 and set a "buy" rating for the company in a research report on Wednesday, July 22nd. JPMorgan Chase & Co. dropped their price objective on Danaher from $275.00 to $245.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 22nd. Deutsche Bank Aktiengesellschaft reiterated a "buy" rating and set a $240.00 target price on shares of Danaher in a report on Wednesday, July 22nd. Finally, Wolfe Research cut Danaher from an "outperform" rating to a "peer perform" rating in a research note on Monday, June 1st. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the company's stock. According to MarketBeat, Danaher presently has an average rating of "Moderate Buy" and an average target price of $228.91.

Danaher Stock Up 6.2%

Danaher stock opened at $211.92 on Thursday. The company has a 50 day moving average of $194.30 and a 200-day moving average of $192.44. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The stock has a market capitalization of $148.98 billion, a PE ratio of 37.64, a price-to-earnings-growth ratio of 2.49 and a beta of 0.78.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping analysts' consensus estimates of $1.85 by $0.09. The business had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm's quarterly revenue was up 5.5% on a year-over-year basis. During the same period last year, the business posted $0.77 earnings per share. On average, equities research analysts anticipate that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Danaher Company Profile

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source